ALLISON BOWEN: Open Payments
NPI 1982730917 · LA GRANGE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 41 payments from 13 companies in 2025. Trend: 2023 $937 · 2024 $1,179 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $286 |
| Novo Nordisk Inc | 8 | $149 |
| Lilly USA, LLC | 3 | $58 |
| Amgen Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VRAYLAR, UBRELVY, Wegovy, JARDIANCE, QULIPTA, Ozempic, OTEZLA, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
